Fact-checked by Grok 2 weeks ago

Harry Benjamin

Harry Benjamin (January 12, 1885 – August 24, 1986) was a German-born American endocrinologist and sexologist recognized for initiating systematic medical interventions for individuals experiencing transsexualism, a condition he characterized as an intractable mismatch between psychological sex and anatomical sex. After studying medicine in Germany and immigrating to the United States in 1913 amid the outbreak of World War I, Benjamin built a career in endocrinology and geriatrics, leveraging hormone therapies initially developed for aging patients to address transsexual distress starting in the 1940s. His clinical practice emphasized empirical observation over dominant psychoanalytic explanations, treating hundreds of patients with estrogen or testosterone to induce secondary sex characteristics aligned with their self-perception, often in collaboration with surgeons for genital reconstruction. Benjamin's seminal work, The Transsexual Phenomenon (1966), synthesized over a decade of case studies to delineate transsexualism as distinct from and , proposing a sex-orientation scale and advocating multidisciplinary evaluation prior to irreversible procedures. This text laid foundational criteria for diagnosis and management, influencing the formation of professional bodies like the Harry Benjamin International Association (later WPATH), though his outsider status in mainstream medicine positioned him as a persistent against institutional resistance. Reports from his patients underscored subjective improvements in following hormonal and surgical interventions, which Benjamin attributed to biological underpinnings potentially rooted in , predating contemporary genetic and neuroscientific inquiries. Despite acclaim for humanizing transsexual care, Benjamin's legacy includes debates over the long-term outcomes of youth interventions he endorsed in select cases and the causal mechanisms of the condition, with some empirical reviews questioning sustained satisfaction rates post-surgery amid evolving diagnostic paradigms. His approach prioritized patient-reported alleviation of through physiological alignment, reflecting a pragmatic realism that challenged era-specific taboos while anticipating critiques of over-medicalization in biased institutional narratives.

Early Life and Education

Childhood and Family Background

Harry Benjamin was born on January 12, 1885, in , , into a prosperous middle-class family. His father, Julius Benjamin, worked as a , providing financial stability that supported the household's assimilated lifestyle. As the eldest of three children, Benjamin grew up in a Lutheran environment, with his mother and a father who had converted from to , reflecting the era's trends toward religious assimilation among urban Jewish-origin families. The family's home avoided open discussions of sexuality, emphasizing decorum and conformity in line with bourgeois Prussian values. Berlin's dynamic cultural milieu, including early access to technologies like the , offered exposure to and music, sparking Benjamin's childhood fascination with performers such as and . He attended the Königliches Wilhelms-Gymnasium for , receiving a rigorous classical training that prepared him for higher studies amid the city's intellectual vibrancy. This upbringing instilled a sense of upward mobility typical of Berlin's , though subtle prejudices tied to his father's Jewish heritage occasionally surfaced despite the family's Christian orientation. Such dynamics contributed to Benjamin's early navigation of social expectations and in pre-World War I .

Medical Training in Germany

Harry Benjamin, born in in 1885, commenced his medical studies in around 1903, attending universities including those in before completing his Doctor of Medicine degree at the in 1912. His doctoral dissertation focused on , reflecting the era's emphasis on infectious diseases amid 's advanced initiatives. The German medical curriculum at the time demanded extensive clinical rotations, laboratory work, and examinations, fostering a commitment to and physiological understanding that characterized pre-World War I training. Post-graduation, Benjamin engaged in practical training in and , applying foundational skills in and treatment within Berlin's system, where exposure to emerging on glandular functions laid groundwork for later interests in hormonal influences. This period coincided with pivotal discoveries in , such as thyroid hormone isolation in 1914, though Benjamin's immediate focus remained on general rather than specialized . The rigorous, data-driven approach of German academia instilled habits of observation and skepticism toward unverified theories, shaping his enduring preference for verifiable patient outcomes over speculative etiologies.

Immigration and Early Professional Career

Arrival and Settlement in the United States

Harry Benjamin first arrived in the United States in February 1913, traveling from to to assist a promoting an unverified treatment for . This professional opportunity aligned with his early medical interests, though the collaboration involved questionable methods later regarded as . Initially intending a temporary visit, Benjamin found himself stranded upon the outbreak of in 1914, which disrupted transatlantic travel and prevented his return to . Unable to resume his life in Europe amid the war's uncertainties, Benjamin pursued permanent settlement in the U.S., leveraging his German medical training to adapt to the American system. By 1915, he secured a New York State medical license, enabling legal practice despite challenges in credential recognition for foreign graduates. He established a modest office in Manhattan, navigating initial logistical hurdles such as limited English proficiency and unfamiliarity with U.S. regulatory frameworks for physicians. Settlement proved arduous in the postwar economic turbulence of the , compounded by the starting in 1929, which strained medical practices nationwide through reduced patient affordability and heightened competition. Benjamin sustained his livelihood by focusing on niche endocrinological consultations, though specific financial strains from this era remain undocumented in primary accounts. His Jewish heritage added contextual risks from global antisemitic currents, but primary relocation drivers were wartime stranding and professional rather than immediate in .

Initial Practices in Endocrinology and General Medicine

Upon arriving in in February 1913, Harry Benjamin established a private medical practice that soon specialized in , focusing on glandular therapies to address age-related hormonal imbalances. His work emphasized the therapeutic potential of endocrine interventions for metabolism and behavioral aspects of aging, drawing on early extracts like preparations then available for clinical use. Benjamin's Park Avenue office became renowned for treating affluent patients, such as singers, movie stars, and businessmen experiencing midlife declines, with hormone-based regimens continued into the late . In the , he actively promoted and performed the Steinach —a unilateral vasoligation procedure designed to stimulate testicular rejuvenation and counteract —reporting outcomes from 22 cases in a 1922 article that interpreted results through an endocrine lens. As synthetic hormones emerged, he integrated estrogens from the late and androgens from the mid-1930s to enhance glandular function and alleviate symptoms of metabolic slowdown. Despite prevailing skepticism within the medical establishment toward such rejuvenative techniques, Benjamin cultivated a robust referral network through demonstrated efficacy in patient vitality and his compassionate application of endocrine principles, solidifying his expertise prior to diversifying into other areas.

Entry into Sexology

Influences from European Sexologists

Harry Benjamin's engagement with European sexology began during his medical training in and continued through professional networks in the era. He first encountered , the pioneering sexologist and founder of the (Institute for Sexual Science), at the inaugural International Conference for Sexual Reform on a Sexological Basis held in in 1921. This meeting, facilitated through police official Dr. 's associate Dr. Kopp, initiated a longstanding professional relationship between the two physicians. Throughout the 1920s and into the early 1930s, Benjamin made repeated visits to , where he consulted with Hirschfeld at for Sexual Science, established in 1919 as the world's first dedicated center for sexological research and clinical treatment. The Institute's extensive cataloging of sexual variations—including detailed case studies on , (termed "transvestism" by Hirschfeld in his 1910 Die Transvestiten), and intermediary sexual types—provided Benjamin with empirical models for understanding gender-related nonconformities beyond moralistic or psychiatric pathologization. Hirschfeld's emphasis on biological and psychological continua in , rather than rigid binaries, informed Benjamin's later empirical orientation, distinguishing it from prevailing Freudian or degenerative theories prevalent in early 20th-century . Benjamin's exposure extended to Weimar Berlin's broader clinical landscape, including consultations at specialized facilities where sexologists documented cross-dressing and homosexual behaviors amid the era's relative openness to scientific inquiry into sexuality. These interactions acquainted him with Hirschfeld's advocacy for legal reforms, such as decriminalizing homosexuality via Paragraph 175 repeal efforts, and practical interventions like issuing "transvestite passes" to allow public cross-dressing without arrest. The Nazi regime's ransacking and burning of the Institute's library on May 6, 1933—destroying over 20,000 volumes and irreplaceable patient records—severed this direct lineage, but Benjamin's prior immersion sustained his commitment to evidence-based sexology in exile.

Early Writings on Transvestism

In the early , Harry Benjamin began publishing articles on in medical and journals, framing it as a distinct psychosomatic condition involving periodic for emotional relief and sexual gratification, rather than mere or perversion. His 1953 piece "Transvestism and Transsexualism" in the International Journal of Sexology outlined initial clinical observations from patient consultations, emphasizing 's roots in an innate drive rather than environmental factors. This was followed by his 1954 contribution to the American Journal of Psychotherapy, "Transsexualism and Transvestism as Psychosomatic and Somato-Psychic ," where he described as a bridging and psychic elements, often manifesting in heterosexual men who experienced as a compulsion to alleviate inner tension without desiring permanent anatomical change. Benjamin drew these insights from direct examinations and extensive correspondence with self-identified transvestites, noting patterns of episodic dressing that provided psychological equilibrium without broader social disruption. Benjamin explicitly rejected pathologizing as a mental illness, portraying the "true transvestite" as a harmless variant of integrated into otherwise normal functioning, provided no criminal acts accompanied the behavior. He advocated for societal and legal non-interference, arguing that punitive measures exacerbated distress without addressing the underlying , and recommended supportive counseling or mild hormonal interventions only if requested to mitigate symptoms. This stance contrasted with contemporaneous psychiatric views that often conflated with deviance, positioning Benjamin's work as an early call for destigmatization based on empirical case patterns rather than moral judgment. A core element of Benjamin's analysis was distinguishing from , underscoring that the majority of cases involved heterosexual toward women, with serving as an adjunct to, not a substitute for, normative sexual relations. He observed that while some bisexual elements might appear during episodes of dressing, the baseline attraction remained to the opposite anatomical sex, challenging assumptions of inherent linkage between and same-sex desire. These differentiations relied on self-reports from dozens of correspondents and examinees, highlighting transvestism's prevalence among married, professionally successful men who maintained family lives outside their private inclinations.

Clinical Work with Transsexual Patients

Distinguishing Transvestism from Transsexualism

In the mid-1950s, Harry Benjamin identified a distinct clinical population among his patients who expressed an insistent desire for complete reassignment, including surgical alteration of their genitals and living permanently as , in contrast to transvestites who typically engaged in episodically for psychological relief without seeking such irreversible changes. This differentiation arose from his consultations with individuals whose self-reports revealed a profound incongruence between their psychological and anatomical , marking a departure from earlier conceptualizations that lumped behaviors under alone. Benjamin's empirical observations highlighted transsexuals' persistent , characterized by intense aversion to their primary and secondary characteristics—described by patients as "disgusting deformities that must be changed" or sources of "heart-breaking anguish"—which persisted regardless of and drove demands for medical intervention to align with . In transvestites, however, provided fetishistic or emotional relief, often equated to "a continuous " or tension release, with no equivalent ongoing torment over ; their behaviors were typically solitary, hobby-like, and compatible with retaining their assigned role in daily life. These patterns, drawn from direct patient histories rather than theoretical imposition, underscored transsexualism as a somatopsychic originating from an innate gender misalignment, distinct from the psychosomatic elements of . The 1952 case of , whose hormone s and in garnered international publicity, amplified Benjamin's awareness of this phenomenon by prompting similar individuals to seek his counsel, though he did not perform her procedures. Jorgensen's transformation exemplified the drive for full embodiment, influencing Benjamin's framework without constituting direct on his part, as her care was managed by European colleagues like Christian Hamburger. This public visibility, combined with Benjamin's accumulating case data, solidified his view of transsexualism as a for affected individuals, separable from transvestism's more circumscribed satisfactions.

Diagnostic Framework and Treatment Protocols

Benjamin's diagnostic framework centered on clinical interviews to assess the degree of gender disorientation, employing his Sex Orientation Scale (S.O.S.), a seven-point spectrum ranging from 0 (exclusive identification with natal sex) to 6 (complete transsexualism characterized by rejection of natal sex and full adoption of the opposite). required persistent, intense cross-sex identification from an early age, absence of or severe mental illness, and adult status, with transsexualism posited as a constitutional condition potentially rooted in neuroendocrine factors rather than reversible . Treatment began with administration to induce secondary sex characteristics aligned with the patient's identified sex—primarily estrogens and anti-androgens for male-to-female cases—prioritizing endocrinological based on observed symptomatic relief and Benjamin's prior experience with hormonal therapies in non-transsexual contexts. was recommended concurrently as supportive, focusing on coping and adjustment rather than alteration, given Benjamin's rejection of it as a standalone cure for what he viewed as an innate mismatch. Surgical referral followed only after demonstrated persistence through and a real-life test, wherein patients lived full-time in their affirmed , including , name changes, and societal integration, to confirm functionality and reduce regret risks. Benjamin collaborated with surgeons like Erwin Kohler for vaginoplasties and other procedures, ensuring medical oversight. From the 1960s to 1970s, he managed roughly 1,500 patients, the majority male-to-female (approximately 392 documented in one cohort versus 71 female-to-male).

Case Studies and Patient Outcomes

Harry Benjamin documented outcomes from his clinical practice involving approximately 152 male-to-female patients and 20 female-to-male patients as of 1965, with many receiving and referrals for surgery. Follow-up data, spanning 3 months to 16 years (average 5-6 years), indicated that surgical interventions generally led to improved adjustment for most patients, though results varied by individual circumstances. Among 51 postoperative male-to-female cases reviewed, 17 (33%) achieved good outcomes, 27 (53%) satisfactory, 5 (10%) doubtful, and 1 (2%) unsatisfactory, yielding roughly 86% positive or neutral results based on self-reported , , and psychological relief. Notable cases illustrated these patterns. "Harriet," operated on in her late 20s, reported marital happiness and plans for years post-surgery, despite an internal and delayed healing as complications. "," who transitioned at age 58 and lived as a for nine subsequent years, maintained a stable life without reported regrets. Conversely, "Joan," a 26-year-old post-surgery , succumbed to a amid issues. Pre-treatment occurred in cases like "," a 30-year-old denied , attributed by Benjamin to unaddressed rather than inherent pathology. Regret was rare; among 15 contacted postoperative , none expressed it, though one 64-year-old reported dissatisfaction due to failed and economic hardship. Complications from included fistulas between the neovagina and , requiring douches, urinary issues like urethrocystitis, and necessitating revisions; and insufficient lubrication were also noted. , primarily estrogens for male-to-female patients, carried risks such as and potential cardiovascular effects, though Benjamin emphasized gradual administration to mitigate unknowns. For female-to-male patients, limited data showed benefits in 15 of 20 cases from hormones and procedures like , with seven achieving good or excellent results post-mastectomy. Long-term tracking was constrained by patient mobility and reluctance to follow up, with Benjamin attributing occasional suicides or poor outcomes more to societal and pre-existing despair than treatment itself. Aggregate from his suggested low regret rates in the 1-2% range for operated cases, contrasting with higher pretreatment self-harm attempts (e.g., 4 of 152 males attempted genital ).
Outcome CategoryMale-to-Female (n=51 postoperative)Notes
Good17 (33%)Full social/psychological adjustment
Satisfactory27 (53%)Partial relief, minor ongoing issues
Doubtful5 (10%)Ambiguous improvement
Unsatisfactory1 (2%)Regret or failure

Key Publications and Theoretical Contributions

The Transsexual Phenomenon (1966)

The Transsexual Phenomenon, published in 1966 by Julian Press, synthesized Harry Benjamin's clinical observations from over 200 male and 27 female patients into a framework distinguishing transsexualism from transvestism and advocating biological interventions over psychological adjustment. The book detailed 51 male and 11 female cases involving surgical conversions, emphasizing persistent gender disharmony unresponsive to therapy. Benjamin proposed an inborn predisposition, potentially rooted in endocrine factors such as prenatal hormonal influences or hypogonadism observed in 40% of cases, leading to a neurophysiological mismatch between brain gender identity and somatic sex. He integrated genetic possibilities, like associations with Klinefelter syndrome, and environmental conditioning as secondary contributors, but stressed the etiology's obscurity pending further research. Benjamin critiqued dominant psychoanalytic paradigms, which attributed transsexualism to aberrant childhood experiences or unresolved Oedipal conflicts, as empirically unsupported and clinically futile. He cited instances where years of failed to alleviate distress, arguing such approaches imposed mind-over-body conformity that exacerbated suffering rather than addressing an organic discord. In contrast, he endorsed —such as estrogens for males—and surgical procedures like , , and , reporting improved psychosocial functioning in operated patients who integrated as their identified . This medical realism prioritized alleviating verifiable symptoms through bodily alignment, drawing on case outcomes where non-intervention led to risks or institutionalization. The work's empirical foundation rested on anecdotal clinical data without controlled studies or long-term follow-ups, limiting causal inferences to hypothesis rather than verification. Benjamin acknowledged surgical techniques' imperfections, including complication risks and functional inadequacies, alongside the absence of diagnostics. While advancing recognition of transsexualism as a treatable condition distinct from fetishistic , the model's reliance on observed patterns over experimental evidence invited scrutiny, particularly regarding unproven endocrine etiologies and exclusion of variants. In The Transsexual Phenomenon (1966), Harry Benjamin introduced the Sex Orientation Scale (S.O.S.), a seven-point classification system (levels 0 through 6) designed to differentiate degrees of sex and gender role disorientation among males exhibiting transvestic or transsexual tendencies. The scale progressed from level 0, representing typical male heterosexual orientation with no cross-gender elements, to level 6, denoting full transsexualism characterized by complete psychic identification with the female role and pursuit of surgical sex reassignment. Benjamin emphasized a continuum influenced by the Kinsey scale's approach to sexual orientation but adapted to assess gender identity variance, distinguishing fetishistic transvestism at lower levels from profound cross-sex identification at higher ones. The S.O.S. integrated three evaluative dimensions: somatic (physical manifestations, such as frequency or post-hormonal/surgical changes), (internal conviction, ranging from mild discomfort to feeling "trapped in the wrong "), and (behavioral , including part- or full-time living in role). Levels 1–3 captured transvestic subtypes (pseudo-, fetishistic, and true), where was periodic or habitual but retained male identity; levels 4–6 marked transsexual progression, with increasing demands for hormones and to align with . Benjamin noted that higher levels often correlated with diminished and or bisexual orientations post-transition, based on observed patient patterns.
LevelTypeSomatic GradeSocial Grade
0Normal maleNoneMasculineHeterosexual male
1Pseudo-transvestiteMinimal (occasional dressing)Slight gender discomfortMinimal cross-living; heterosexual
2Fetishistic transvestiteModerate (frequent dressing)Moderate discomfortOccasional ; heterosexual
3True transvestiteModerate to strongStrong discomfortPartial cross-living; heterosexual
4Nonsurgical MarkedHigh (wavering )Moderate cross-living; /
5True (moderate)HighSevere (feminine conviction)Full cross-living; low
6True (high intensity)Complete (post-surgical)Complete female Fully integrated as female
Benjamin derived the empirically from clinical observations of approximately 150 patients by 1965, supplemented by case histories, autobiographies, and responses to in over 100 cases. He analyzed factors in 122 patients, finding no clear environmental causation in 56% and doubtful evidence in 26%, favoring innate predispositions observable through consistent self-reports of childhood cross-gender behaviors. Physiological tests, such as assays and chromosomal evaluations, supported assessments but did not alter the psychic-social typology. This contributed to subsequent diagnostic frameworks by providing a graduated model for gender incongruence, informing the DSM-III (1980) criteria for gender identity disorder through its emphasis on persistent cross-sex identification over mere . Benjamin's underscored measurable variances in patient presentations, aiding clinicians in tailoring interventions from supportive at lower levels to medical transition at higher ones.

Establishment of Professional Standards

Founding of the Harry Benjamin International Gender Dysphoria Association

The Harry Benjamin International Gender Dysphoria Association (HBIGDA) was conceived during the Fifth International Symposium on in , in 1977, following the dissolution of the Erickson Educational Foundation, which had previously sponsored such gatherings. It was formally approved at the Sixth Symposium in in 1979 and incorporated as a nonprofit on September 14, 1979, in by Paul Walker, Walter Meyer III, and Alice Webb. Founding members included Paul A. Walker (psychologist and founding president), Richard Green (psychiatrist), Donald R. Laub (surgeon), and Leah Schaefer (psychoanalyst), reflecting an initial emphasis on multidisciplinary collaboration among professionals, endocrinologists, and surgeons to address the clinical needs of gender-dysphoric patients. Named in honor of Harry Benjamin, the endocrinologist whose clinical observations had highlighted the distinction between and transsexualism since the , HBIGDA aimed to institutionalize peer-reviewed protocols for patient evaluation and referral amid a lack of broader medical consensus on care. Benjamin, then in his mid-90s and operating largely in professional isolation due to skepticism from mainstream and , endorsed the effort as a means to facilitate surgeon referrals and establish shared standards grounded in empirical case outcomes rather than purely psychoanalytic approaches. The association's formation responded to practical challenges, such as coordinating and surgical interventions, by fostering networks among specialists who had treated small numbers of patients based on Benjamin's diagnostic framework. Early activities centered on symposia, which empirically examined eligibility for interventions through presentations on histories, hormonal responses, and surgical results, prioritizing observable outcomes over theoretical etiologies. These gatherings, building on prior symposia since 1969, emphasized multidisciplinary input to refine referral practices and mitigate risks, such as postoperative regret, informed by Benjamin's decades of follow-up data on over 1,500 cases. By uniting isolated practitioners, HBIGDA sought to elevate the field from ad hoc clinical work to a structured professional domain, countering institutional reluctance evident in the era's limited insurance coverage and ethical debates.

Development of Early Standards of Care

The Harry Benjamin International Gender Dysphoria Association (HBIGDA), founded in 1979 and drawing directly from Benjamin's clinical framework, issued the first Standards of Care (SOC) that year to guide the evaluation and treatment of transsexual patients. These initial guidelines mandated a rigorous diagnostic process by qualified mental health professionals to confirm persistent gender dysphoria, distinguishing it from transient or comorbid conditions like fetishistic cross-dressing or psychiatric disorders. Hormone therapy was permitted only after this diagnosis, typically following a period of psychotherapy to assess the stability of the patient's identity and rule out reversible factors, reflecting Benjamin's emphasis on verifiable, longstanding incongruence rather than immediate accommodation of self-reported desires. Central to the 1979 SOC was a staged progression designed to test commitment and reduce postoperative regret rates, which Benjamin had observed could exceed 10% in less vetted cases from earlier European clinics. Candidates for cross-sex hormones were required to demonstrate psychological readiness, with therapy often spanning months to years before initiation. Genital surgery was prohibited without at least one year of continuous hormone administration and a "real-life experience" (RLE) in the desired social role, during which patients navigated daily life, employment, and relationships without reverting to their birth sex presentation. This gatekeeping aimed to ensure interventions addressed a profound, immutable mismatch rather than situational distress, prioritizing outcomes where patients achieved sustained adaptation over rapid medicalization. For adolescents, the early SOC advocated extreme caution, limiting interventions to reversible measures like counseling or puberty-delaying analogs only in exceptional cases of severe, documented persistence into late puberty, with irreversible steps deferred until adulthood. Benjamin's influence here stemmed from his sexology scale, which weighted higher degrees of transsexualism by lifelong conviction and adult-onset irreversibility, viewing juvenile cases as often desisting without intervention—rates he estimated at up to 80% based on follow-up data from his practice. This approach sought causal fidelity by favoring empirical persistence over acquiescence to youthful declarations, thereby safeguarding against iatrogenic harm in developmentally fluid periods.

Criticisms, Controversies, and Alternative Perspectives

Debates with Psychiatrists on Psychotherapy vs. Medical Intervention

Benjamin engaged in ongoing debates with psychiatrists and psychoanalysts who viewed transsexualism primarily as a psychological disorder amenable to curative , often attributing it to unresolved oedipal conflicts, pre-oedipal fixations, or delusional defenses against underlying . Prominent critics, including psychoanalyst Charles Socarides, classified transsexualism as a severe perversion or rooted in developmental arrests, advocating intensive to uncover and resolve these psychic origins rather than endorsing hormonal or surgical interventions, which they saw as enabling . Socarides and like-minded professionals argued that medical treatments bypassed essential therapeutic work, potentially exacerbating issues by affirming what they deemed a pathological rejection of biological reality. In response, Benjamin maintained that transsexualism possessed a constitutional or biological component resistant to purely psychotherapeutic resolution, drawing on clinical observations from over 1,500 cases where extended analysis failed to alleviate core and sometimes intensified patient distress, such as through deepened feelings of invalidation or prolonged denial of identity. He cited empirical outcomes showing rapid symptom relief— including reduced suicidality and improved social functioning—following hormone administration, even in patients previously deemed "treatment-resistant" by psychiatrists, positioning medical intervention as causally aligned with the condition's underpinnings rather than a psychological overlay. While acknowledging psychotherapy's role in screening for comorbidities or aiding postoperative adjustment, Benjamin critiqued psychiatric conservatism as empirically unsubstantiated, noting low postoperative rates (under 1% in his ) compared to high pretreatment attempts (up to 50% in some reports). These debates highlighted tensions between psychoanalytic , which prioritized intrapsychic causation, and Benjamin's endocrinological framework emphasizing observable physiological responses to treatment. Critics countered that Benjamin's approach risked by sidelining rigorous psychiatric , potentially overlooking co-occurring conditions like or personality disorders that mimicked or compounded , though Benjamin mandated consultations and reserved final decisions for medical judgment when proved futile. His advocacy ultimately shifted clinical paradigms toward multimodal care, reducing acute suffering in cases, but sparked enduring concerns over insufficient gatekeeping in early protocols.

Concerns Over Long-Term Efficacy and Ethical Issues

Critics have questioned the long-term efficacy of Benjamin's treatment protocols, which emphasized and surgery for select patients, due to the absence of randomized controlled trials or placebo-controlled studies that could establish causality between interventions and sustained improvements in . Benjamin's own follow-ups, drawn from small clinical samples of dozens to hundreds of patients, reported regret rates as low as 1-2%, but these lacked systematic long-term tracking beyond a few years and were susceptible to , as dissatisfied patients may have disengaged from care. Subsequent analyses of early postoperative cohorts have similarly highlighted methodological gaps, including short observation periods and no comparison to non-surgical outcomes, complicating attributions of benefits to medical amid confounding factors like or social adaptation. Contemporary evidence underscores data limitations in affirming universal efficacy, with rates in modern studies varying from 2.1% for internal motivations to 10-13% overall, often exceeding historical claims and linked to unresolved comorbidities or shifts in self-perception. A 2011 of 324 post-sex reassignment individuals found elevated risks of mortality, suicidality, and psychiatric hospitalization compared to matched controls, persisting up to 30 years post-treatment, suggesting that interventions may not resolve underlying vulnerabilities and could exacerbate them without addressing root causes such as or neurodevelopmental factors. These findings, derived from national registries rather than clinic self-reports, contrast with affirmative narratives in healthcare literature, where methodological rigor is often lower due to ethical barriers to withholding treatment, perpetuating reliance on observational data prone to bias. Ethical concerns center on the irreversibility of interventions like or , which preclude fertility without contemporaneous preservation techniques—rare in Benjamin's era—and carry risks such as from estrogen-induced in male-to-female cases or cardiovascular complications from testosterone in female-to-male. Informed consent processes face challenges when long-term uncertainties, including potential regret amid evolving identity or external pressures, are not fully conveyed, particularly given the absence of high-quality prognostic data at the time. Proponents of alternative approaches, such as extended or intensive , argue these prioritize reversible explorations of dysphoria's —debated as innately biological versus environmentally influenced—over hasty , citing ethical imperatives to minimize harm from unproven causal pathways. Such critiques highlight trade-offs in prioritizing affirmation, as institutional biases in and may underemphasize non-affirmative to avoid stigmatizing patients.

Heteronormative Assumptions and Binary Focus in His Work

Benjamin's framework for transsexualism presupposed a strict of male and female roles, positing that individuals experienced an innate mismatch between their psychological and anatomical sex, necessitating to fully embody socially, legally, and sexually. In The Transsexual Phenomenon (1966), he described transsexuals as seeking to "function as members of ," with successful outcomes involving integration into traditional roles, such as male-to-female patients living as "inconspicuous girls" or pursuing marriage and motherhood. This orientation reflected mid-20th-century endocrinological and psychiatric understandings, where was tied to dimorphic biological norms rather than fluidity or spectra. Central to his model was the expectation of heterosexual adjustment post-transition, which he viewed as evidence of authentic . Benjamin noted that many male-to-female transsexuals were attracted to men, pursuing "normal boyfriends who treat them as girls" and aiming for legal after surgery to overcome anatomical barriers to such relationships. His Sex Orientation Scale (S.O.S.) reinforced this by classifying "true transsexuals" (Types V and VI) as those with moderate to high intensity disorientation coupled with predominantly or exclusively heterosexual in the target —equivalent to ratings of 4-6 or 6, meaning attraction primarily or solely to men pre-transition for male-to-female cases, aligning with post-transition . Case studies, such as Clara's 30-year to a man and multiple orgasms in heterosexual contexts post-surgery, exemplified this desired outcome. Benjamin expressed skepticism toward transsexuals exhibiting homosexual inclinations relative to their birth sex, distinguishing them from "true" cases and often aligning them closer to or . He observed that transsexuals frequently disliked homosexuals and rejected homosexual experiences as unsatisfactory, insisting that transsexual attraction to the anatomical same sex did not constitute because "they feel they belong to the sex to that of the chosen partner." Such patients were deemed rarer and subject to greater psychiatric scrutiny, with lower S.O.S. types (e.g., ) showing more variable orientations not fully endorsing heterosexual . While this approach legitimized and surgery for binary-identified patients whose post-transition goals matched heterosexual norms—comprising the majority of his clinical successes and enabling "happier futures" through role alignment—critics contend it imposed heteronormative gatekeeping that marginalized or identities. By prioritizing androphilic male-to-female cases as paradigmatic, Benjamin's criteria excluded gynephilic individuals, potentially delaying care for those not fitting the model and embedding expectations of in early standards of care. Contemporary reassessments, informed by greater visibility of gender diversity, argue that his binary-heterosexual emphasis pathologized variance outside these norms, framing deviations as lesser forms of the condition rather than valid expressions, though his era-limited observations aligned with the patient demographics he encountered.

Broader Contributions and Later Years

Work in Endocrinology and Gerontology

Harry Benjamin established a clinical practice in specializing in and , where he applied hormone therapies to address age-related endocrine deficiencies in non-transgender patients. His work emphasized biological interventions over psychosomatic interpretations, positing that glandular imbalances were primary drivers of symptoms like , reduced vitality, and in older adults. Benjamin's approach drew from early 20th-century advances in hormone isolation, advocating empirical testing of glandular extracts and sex steroids to restore physiological function. In treating elderly men, Benjamin prescribed testosterone to counteract andropause-like symptoms, reporting improvements in energy, , and overall based on patient outcomes. He personally administered testosterone to himself into advanced age, reflecting confidence in its efficacy for mitigating . For women, he combined estrogens and androgens in geriatric patients, administering these to 88 individuals aged 43 to 73 under the hypothesis that gonadal hormone deficits universally accompany aging. These regimens targeted metabolic disturbances and sexual function, with Benjamin documenting subjective gains in physical and psychological vigor, though long-term data remained limited by the era's methodological constraints. Benjamin's publications, such as his 1949 article "Endocrine Gerontotherapy: The Use of Combinations in Female Patients," underscored a causal framework wherein supplementation directly addressed root endocrine failures rather than secondary psychological factors. This perspective aligned with his broader rejection of purely environmental or mental explanations for physiological decline, favoring observable hormonal correlations from clinical observations. By the late 1940s, however, his aggressive protocols for faced growing amid emerging evidence of risks like cardiovascular effects, positioning his methods as innovative yet increasingly divergent from mainstream .

Personal Life and Death

Harry Benjamin married Gretchen Amelung in 1925, a union that lasted until his death and to whom he dedicated his 1966 book The Transsexual Phenomenon. The couple had no children and resided frugally in a Murray Hill apartment in , where Benjamin maintained a modest lifestyle despite his professional success. He continued a lifelong hobby of playing the into his later years, reflecting personal resilience amid a marked by professional isolation on certain topics. Benjamin attributed his exceptional in part to disciplined habits and his interests in , including hormone therapies for aging, which he applied to geriatric patients and possibly himself. He received late-career recognitions from medical and organizations, including awards documented through 1975, and persisted in consulting patients into his eighties before retiring around age 90. Benjamin died on August 24, 1986, at age 101 in his apartment, succumbing to natural causes associated with advanced age. His endurance underscored a personal fortitude that paralleled his unconventional professional pursuits.

Legacy and Contemporary Impact

Influence on Modern Transgender Healthcare

The Harry Benjamin International Gender Dysphoria Association (HBIGDA), founded in 1979 and named in honor of Benjamin, directly extended his clinical framework by publishing the first Standards of Care () that year, outlining protocols for diagnosing , initiating , and approving surgeries after psychological assessment. These initial SOC documents, revised in subsequent versions through 1981, codified Benjamin's emphasis on a multidisciplinary approach involving endocrinologists, surgeons, and therapists to evaluate patient suitability for irreversible interventions, thereby establishing a template for medical treatment that prioritized phenotypic alignment with identified over exploratory alone. HBIGDA's SOC influenced the proliferation of specialized gender clinics in the United States and during the 1980s and 1990s, standardizing practices that had previously varied widely and lacked consensus. Upon HBIGDA's renaming to the World Professional Association for Transgender Health (WPATH) in 2007, the SOC evolved into versions 7 (2012) and 8 (2022), retaining core elements from Benjamin's model such as real-life experience requirements and informed consent processes, which continue to underpin global guidelines adopted by bodies like the Endocrine Society and various national health services. This continuity ensured Benjamin's causal role in shifting transgender healthcare from ad hoc interventions to protocol-driven care, facilitating access for individuals with persistent, severe dysphoria by legitimizing medical pathways in institutional settings previously resistant to such treatments. However, the entrenched medicalization inherent in these standards has been noted to marginalize non-interventionist alternatives, potentially foreclosing empirical exploration of psychosocial factors in dysphoria resolution prior to physical changes. Benjamin's legacy in this domain empirically marked a from outright denial of transsexualism as a treatable condition—prevalent in mid-20th-century —to affirmative models, enabling thousands of procedures worldwide under structured oversight, though subsequent reviews highlight the need for rigorous longitudinal outcome studies to validate long-term efficacy beyond anecdotal reports from early cohorts. While achieving reduced procedural risks through standardized preoperative evaluations, the model's binary focus on cross-sex hormones and as primary remedies has constrained diversification toward reversible or watchful-waiting options in milder presentations.

Reassessments in Light of Current Evidence on Treatments

Recent systematic reviews of longitudinal studies indicate that 60-90% of children and adolescents diagnosed with desist from their by adulthood without medical intervention, with desistance rates averaging around 80% in pre-pubertal cohorts followed into maturity. These findings, drawn from clinic-based cohorts in the and spanning decades, challenge models assuming persistence and underscore the risks of early , as desistance often correlates with puberty's onset and resolution of comorbidities like or . The 2024 Cass Review, commissioned by the , concluded that evidence for blockers and hormones in youth is "remarkably weak," with no robust randomized controlled trials (RCTs) demonstrating benefits for or reduction, and potential harms including loss and fertility impairment. This led to an indefinite ban on blockers for under-18s in December 2024, prioritizing exploratory to address underlying factors over affirmative medical pathways. Similarly, Sweden's 2022 national guidelines, based on systematic evidence assessment, restricted hormones for minors to exceptional cases, citing insufficient proof of net benefits and elevated risks of or persistent psychopathology. In adults, long-term follow-up data reveal persistent elevated risks post-transition; a 2011 of 324 post-sex-reassignment individuals found 19.1 times higher rates and increased psychiatric compared to matched controls, persisting decades after . Reported regret rates hover below 1% in short-term surveys, but methodological flaws—such as 30-50% loss to follow-up and exclusion of —likely underestimate true detransition, which may reach 10-30% in recent youth cohorts per insurance and clinic data. Benjamin's framework, emphasizing psychiatric evaluation, real-life experience, and adult-only interventions, appears prescient in advocating caution against unproven youth treatments amid evidence of social influences and comorbidities driving recent surges in referrals. However, his model's reliance on anecdotal outcomes without RCTs or etiological inquiry into dysphoria's causes—such as neurodevelopmental or environmental factors—limits its applicability, as modern causal research gaps persist despite calls for comorbidity-focused over default . Proponents of affirmation cite risk reductions in observational studies, yet these lack controls for and show no causal superiority over . Skeptics highlight over-medicalization akin to , urging randomized trials to test alternatives like Benjamin's evaluative approach against rapid .

References

  1. [1]
    Harry Benjamin and the birth of transgender medicine - PMC - NIH
    Dec 11, 2023 · Born in Berlin, Benjamin studied medicine at the University of Tübingen but was left stranded in the United States in 1914 at the outbreak ...Missing: biography | Show results with:biography
  2. [2]
    THE TRANSSEXUAL PHENOMENON* - Benjamin - 1967
    This paper, presented as an Introduction to the eight papers that follow, was given at a meeting of the Division on January 16, 1967.<|separator|>
  3. [3]
    Transsexuality Expert, 90, Recalls 'Maverick' Career - The New York ...
    Jan 11, 1975 · Dr. Benjamin is generally credited with having been the first to see that transsexualism was a different matter than homosexuality or ...
  4. [4]
    Wondrous Transformations - UNC Press
    Sep 26, 2023 · Harry Benjamin (1885–1986), a German-born endocrinologist, was a pivotal figure in the development of transgender medicine.
  5. [5]
    Harry Benjamin: A Pioneer in Transgender Care - Free Essay Example
    Mar 14, 2020 · Harry Benjamin was born in Berlin, Germany on January 12, 1885 to a German mother and Jewish father. He was the oldest of three siblings.Missing: family | Show results with:family
  6. [6]
    Harry Benjamin (1884 - 1986) endocrinologist, gerontotherapist ...
    Oct 1, 2012 · Harry Benjamin was born in Berlin, the eldest of three children. His father, Julius Benjamin, was a prosperous stockbroker, initially Jewish, who had converted ...Missing: biography | Show results with:biography
  7. [7]
    Harry Benjamin, the Maverick - Contingent Magazine
    Jul 28, 2024 · A maverick physician, the science of hormones, and the birth of the transgender revolution reveals the historicity of this ongoing battle.
  8. [8]
    HARRY BENJAMIN DIES AT 101; SPECIALIST IN TRANSSEXUALISM
    Aug 27, 1986 · Dr. Benjamin, a banker's son, was born in Berlin, studied at universities in Berlin and elsewhere in Germany and came to the United States in ...
  9. [9]
    [PDF] Harry Benjamin and the Development of Transgender Medicine in ...
    Dr. Harry Benjamin leant medical legitimacy to transsexualism with the publication of. The Transsexual Phenomenon in 1966. Using Benjamin's published works ...Missing: military | Show results with:military
  10. [10]
    Trans Medical Care at the Office of Dr. Harry Benjamin
    Harry Benjamin, who in 1948, became one of the first physicians in the U.S. to work with transgender individuals, first providing treatment and care from this ...
  11. [11]
    Harry Benjamin - Wikipedia
    Harry Benjamin (January 12, 1885 – August 24, 1986) was a German-American endocrinologist and sexologist, widely known for his clinical work with transgender ...
  12. [12]
    The Birth of Transgender Science - The Gay & Lesbian Review
    Sep 2, 2024 · Harry Benjamin. Jorgensen, of course, was the Danish-American former GI who had sought medical treatment in Denmark to achieve hormonal “sex ...
  13. [13]
    REPORT OF 22 CASES WITH ENDOCRINE INTERPRETATION
    HARRY BENJAMIN, M.D.; THE- STEINACH OPERATION: REPORT OF 22 CASES WITH ENDOCRINE INTERPRETATION, Endocrinology, Volume 6, Issue 6, 1 November 1922, Pages 7.
  14. [14]
    Harry Benjamin- The Transatlantic Commuter - Archive for Sexology
    Benjamin: I met him in 1921 at Hirschfeld's first congress in Berlin. This was the International Conference for Sexual Reform on a Sexological Basis at the ...Missing: Weimar | Show results with:Weimar
  15. [15]
    The first Institute for Sexual Science (1919-1933)
    Harry Benjamin, a friend and colleague of Hirschfeld's, further developed his studies on transsexuality in the States. It was not until the 60s that this topic ...
  16. [16]
    Harry Benjamin's first ten cases (1938–1953): A clinical historical note
    Benjamin, H. (1953a). Transvestism in the news.J. Am. Med. Assoc. 1–56. Benjamin, H. (1953b). Transvestism and transsexualism.Int. J. Sex. 7: 12–14. Google ...
  17. [17]
    Transsexualism and Transvestism—A Symposium - Psychiatry Online
    Publication Date ... Transsexualism and Transvestism—A Symposium: Transsexualism and Transvestism as Psychosomatic and Somato–Psychic Syndromes. Harry Benjamin, ...
  18. [18]
    [PDF] Transsexualism and Transvestism as Psycho-Somatic and Somato ...
    For them to be attracted to “ other females” appears to be a perversion. Transvestites on the other hand are in the majority heterosexual, although their ...<|separator|>
  19. [19]
    [PDF] The TRANSSEXUAL PHENOMENON Harry Benjamin, MD
    Preface and Acknowledgements. • The symphony of sexes. • Transvestism, Transsexualism, Homosexuality. • The transvestite in older and newer aspects.
  20. [20]
    Dear Doctor Benjamin: Letters from Transsexual Youth (1963–1976)
    Due to his high public profile, Harry Benjamin was often the first contact for those who identified as transsexual in the 1960s and 1970s, ...Missing: internal | Show results with:internal
  21. [21]
    How gender dysphoria and incongruence became medical diagnoses
    Jun 1, 2022 · In ICD-10, Transsexualism designated a desire to live and be accepted as a member of the opposite sex, usually accompanied by a sense of ...
  22. [22]
    International Symposia - WPATH
    In particular, the Harry Benjamin Foundation received over US$60,000 (1964-1968) and the Johns Hopkins Gender Identity Clinic received approximately US$72,000 ( ...Missing: settlement licensure
  23. [23]
    History - WPATH
    Dr. Benjamin was one of the first physicians to work with gender dysphoric persons. A brief biography of Dr. Benjamin is available at the Magnus Hirschfeld ...
  24. [24]
    The rise and fall of gender identity clinics in the 1960s and 1970s
    Apr 1, 2021 · The work of sexologist and endocrinologist Harry Benjamin, MD, in the 1950s and 1960s provided additional momentum to the field within the ...
  25. [25]
    Endocrine Treatment of Transsexual Persons:An ... - Oxford Academic
    Objective: The aim was to formulate practice guidelines for endocrine treatment oftranssexual persons.Evidence: This evidence-based guideline was developed.<|control11|><|separator|>
  26. [26]
    [PDF] The Harry Benjamin International Gender Dysphoria Association's ...
    During the 1960s and 1970s, clinicians used the term true transsexual. The ... are unique to hormonally and surgically treated patients. Postoperative ...
  27. [27]
    Real-Life Test Experience: Recommendations for Revisions to the ...
    Aug 7, 2025 · The real-life test (RLT) or real-life experience (RTE) has been a fixture in the management of gender identity disorder for four decades.
  28. [28]
    Harry benjamin and psychiatrists - ResearchGate
    Aug 10, 2025 · Harry Benjamin, MD, was a pioneer physician who founded the transgender field and coined the term “transsexual.”
  29. [29]
    Unqueering the Double Helix: Conversion Therapists, the “Gay ...
    Sep 30, 2025 · In 1992, Nicolosi joined forces with psychotherapist Benjamin Kaufman and longtime conversion therapist Charles Socarides to found NARTH.
  30. [30]
    Why Therapists Trans Away the Gay - by Glenna Goldis - Bad Facts
    May 22, 2024 · Socarides opposed gender medicine. He also opposed homosexual sex. He devoted his career to developing methods of conversion therapy for gays, ...
  31. [31]
    Harry Benjamin and Psychiatrists
    SUMMARY. Harry Benjamin, MD, was a pioneer physician who founded the transgender field and coined the term “transsexual.” Benjamin drew.Missing: World War military service
  32. [32]
    Harry Benjamin and Psychiatrists - Taylor & Francis Online
    Oct 21, 2008 · This paper chronicles changes in the author's own life and conceptual thinking about transsexualism during this time. Some years later the ...
  33. [33]
    Long-Term Follow-Up of Transsexual Persons Undergoing Sex ...
    Feb 22, 2011 · Persons with transsexualism, after sex reassignment, have considerably higher risks for mortality, suicidal behaviour, and psychiatric morbidity ...
  34. [34]
    Factors associated with satisfaction or regret following male-to ...
    This study examined factors associated with satisfaction or regret following sex reassignment surgery (SRS) in 232 male-to-female transsexuals.
  35. [35]
    Quality of life 15 years after sex reassignment surgery for ...
    Objective. To evaluate quality of life and patients' satisfaction in transsexual patients (TS) after sex reassignment operation compared with healthy controls.
  36. [36]
    Factors Leading to “Detransition” Among Transgender and Gender ...
    Of all participants who ever pursued gender affirmation, 10.8% reported lifetime history of detransition due to an external factor and 2.1% reported a lifetime ...Missing: modern | Show results with:modern
  37. [37]
    Gender detransition: A critical review of the literature - PMC - NIH
    An American study based on a 2015 survey (101) with a convenience sample of transgender individuals found a temporary or permanent detransition rate of 13.1% ( ...Missing: modern | Show results with:modern
  38. [38]
    The Detransition Rate Is Unknown - PMC - NIH
    Jun 12, 2023 · The median or average time to detransition or regret range from 3.2 years in Littman (2021) for female-to-male, for a range of medical ...Missing: modern | Show results with:modern
  39. [39]
    A Review of Treatment Regimens, Outcomes, and Adverse Effects
    This review will discuss the endocrinological treatment of male-to-female (M→F) and female-to-male (F→M) transsexual people.Missing: criticisms | Show results with:criticisms
  40. [40]
    Decision-making approaches in transgender healthcare: conceptual ...
    The aim of this paper is to make explicit the conceptual and normative assumptions regarding decision-making and client autonomy.
  41. [41]
    [PDF] An Ethically Appropriate Response to Individuals with Gender ...
    One approach relies on certain protocols set forth in the Harry Benjamin International Gender Dysphoria Association's. Standards of Care for Gender Identity ...
  42. [42]
    Ethical Concerns About Emerging Treatment Paradigms for Gender ...
    Aug 4, 2025 · The sociological momentum to recognize and accommodate to trans phenomena has posed ethical dilemmas for endocrinologists, mental health ...
  43. [43]
    Harry Benjamin, Transsexualism and the Problem of Heteronormativity
    This article examines Harry Benjamin's work on transsexuality from the standpoint of the interrelations between science, politics and clinical intervention.
  44. [44]
    Endocrine Gerontotherapy The Use of Sex Hormone Combinations ...
    Abstract. On the theory that endocrine deficiencies always accompany the aging process Dr. Benjamin administered gonadal hormones to 88 women aged 43 to 73.
  45. [45]
    DEDICATION Charles L. Ihlenfeld, M.D. Harry Benjamin Foundation ...
    Harry Benjamin has been a ... innovative use of hormones in the geriatric population. ... livered his first scientific lecture on an endocrine sub-.
  46. [46]
    [PDF] Wondrous Transformations | Trans Reads
    Oct 10, 2024 · Archiv: Harry Benjamin. Page 95. 79. Harry Benjamin visiting the Institute for Sex Research. Photographer William Dellenback. From the ...
  47. [47]
    Finding Aid to the Harry Benjamin Licenses and Awards, 1915-1975
    Harry Benjamin was born in Berlin, Germany, in 1885. He moved to New York in the 1920s and started a practice focusing on endocrinology and gender identity.Missing: exposure early career
  48. [48]
    SOC8 History - WPATH
    SOC8 is the first version developed using an evidence-based approach, with previous versions published in 1979, 1980, 1981, 1990, 1998, 2001, 2011, and 2012.Missing: HBIGDA | Show results with:HBIGDA
  49. [49]
    The 2011 WPATH Standards of Care and Penile Reconstruction in ...
    The delineation of conditions involving GD started in Germany in the 19th century [5], but it was Harry Benjamin's publication “The transsexual phenomenon” on ...
  50. [50]
    Mission and Vision - WPATH
    The World Professional Association for Transgender Health (WPATH), formerly known as the (Harry Benjamin International Gender Dysphoria Association (HBIGDA) ...
  51. [51]
    False Assumptions Behind Youth Gender Transitions - SEGM
    Dec 30, 2022 · Further, the high rate of childhood desistance from gender dysphoria before maturity, (61-98%) and growing evidence of desistance among youth ...
  52. [52]
    Do children grow out of gender dysphoria? - Transgender Trend
    On average 80% of children change their minds and do not continue into adulthood as transgender. Some of these studies are very old, the first being published ...
  53. [53]
    Exploring Desistance in Transgender and Gender Expansive Youth ...
    This literature review aims to provide an overview of the literature on desistance and how desistance is defined.
  54. [54]
    Cass Review Final Report
    No information is available for this page. · Learn why
  55. [55]
    The Final Cass Review and the NHS England Response - SEGM
    Apr 11, 2024 · This is not a “new development” as the problems with using puberty blockers for gender dysphoria were already part of the interim Cass Report, ...
  56. [56]
    Ban on puberty blockers to be made indefinite on experts' advice
    Dec 11, 2024 · Puberty blockers for the treatment of gender incongruence and/or gender dysphoria in under 18s were banned temporarily in May 2024 after the ...
  57. [57]
    Summary of Key Recommendations from the Swedish National ...
    Feb 27, 2022 · Three of the recommendations provide guidance for social support for gender dysphoric youth and their families; nine focus on the assessment of ...
  58. [58]
    Long-term follow-up of transsexual persons undergoing sex ...
    Feb 22, 2011 · Persons with transsexualism, after sex reassignment, have considerably higher risks for mortality, suicidal behaviour, and psychiatric ...
  59. [59]
    Long-Term Follow-Up of Transsexual Persons Undergoing Sex ...
    This study found substantially higher rates of overall mortality, death from cardiovascular disease and suicide, suicide attempts, and psychiatric ...
  60. [60]
    Accurate transition regret and detransition rates are unknown - SEGM
    Sep 11, 2023 · A new paper by Cohn, “The Rate of Detransition is Unknown,” reviews common limitations of “regret” studies and demonstrates that hormone discontinuation, ...
  61. [61]
    Regret after Gender-affirmation Surgery: A Systematic Review and ...
    Mar 19, 2021 · The aim of this study was to evaluate the prevalence of regret in transgender individuals who underwent GAS and evaluate associated factors.
  62. [62]
    The gender-affirming model of care is incompatible with competent ...
    Mar 19, 2024 · The gender-affirming model of care (GAMOC), assert without evidence that pathology plays no part in the development of gender diversity.Missing: Harry Benjamin
  63. [63]
    Psychological and Physical Health Outcomes Associated with ...
    Jul 10, 2025 · Gender-affirmation has been shown to alleviate symptoms of depression [54,55], anxiety [55,56], suicidality [55], and self-harm [56]. For ...